Lista de obras - A Alama - Dominio Público Uruguay

ANTISENSE OLIGONUCLEOTIDES AS THERAPEUTIC AGENTS

artículo científico publicado en 1997

Afatinib and Erlotinib in the treatment of squamous-cell lung cancer

artículo científico publicado en 2018

Afatinib for the treatment of advanced non-small-cell lung cancer.

artículo científico publicado en 2014

Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition.

artículo científico publicado en 2014

Antitumor activity of a new orally active organotin compound: a preliminary study in murine tumor models

artículo científico publicado en 2002

Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer

artículo científico publicado en 2019

Belagenpumatucel-L for the treatment of non-small cell lung cancer

artículo científico

CD133-Positive Cells from Non-Small Cell Lung Cancer Show Distinct Sensitivity to Cisplatin and Afatinib

artículo científico publicado en 2015

Caveolin‐1 is essential for metformin inhibitory effect on IGF1 action in non‐small‐cell lung cancer cells ⬇️

artículo científico publicado el 28 de octubre de 2011

Cell kinetics in ovarian cancer. Relationship to clinicopathologic features, responsiveness to chemotherapy, and survival

scientific article published on 01 September 1989

Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.

artículo científico publicado en 2017

Circulating tumor DNA reflects tumor metabolism rather than tumor burden in chemotherapy-naive patients with advanced non-small cell lung cancer (NSCLC): an (18)F-FDG PET/CT study

artículo científico

Clinical Applications of Circulating Tumor Cells in Lung Cancer Patients by CellSearch System

artículo científico publicado en 2014

Control of Cyclin D1 Expression by Antisense Oligonucleotides in Three Ovarian Cancer Cell Lines

artículo científico publicado en 1998

Correlation between B7-H4 and Survival of Non-Small-Cell Lung Cancer Patients Treated with Nivolumab

scientific article published on 01 October 2019

Diethylstilbestrol (DES) and recombinant human growth hormone (rhGH) as modulators of breast cancer proliferative activity

scientific article published on 01 September 1990

Efficacy of motesanib diphosphate in non-small-cell lung cancer

artículo científico publicado en 2014

Exosomes: a new horizon in lung cancer.

artículo científico publicado en 2017

Expression of Ribonucleotide Reductase Subunit-2 and Thymidylate Synthase Correlates with Poor Prognosis in Patients with Resected Stages I-III Non-Small Cell Lung Cancer

artículo científico publicado en 2015

Fibroblast Growth Factor Receptor (FGFR): A New Target for Non-small Cell Lung Cancer Therapy

artículo científico publicado en 2016

In vitro cytotoxic activity of tri-n-butyltin(IV)lupinylsulfide hydrogen fumarate (IST-FS 35) and preliminary antitumor activity in vivo.

artículo científico publicado en 2008

Inhibition of the nicotinic acetylcholine receptors by cobra venom α-neurotoxins: is there a perspective in lung cancer treatment?

artículo científico publicado en 2011

Integrated Somatic and Germline Whole-Exome Sequencing Analysis in Women with Lung Cancer after a Previous Breast Cancer.

artículo científico publicado en 2019

Intraperitoneal cytosine arabinoside administered in sequence with systemic cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer

artículo científico publicado en 1990

Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancer

artículo científico publicado en 2017

Ipilimumab in non-small cell lung cancer and small-cell lung cancer: new knowledge on a new therapeutic strategy.

artículo científico

Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method.

artículo científico publicado en 2015

Microtubule-targeting agents in the treatment of non-small cell lung cancer: insights on new combination strategies and investigational compounds

scientific article published on 07 June 2019

New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancer.

artículo científico publicado en 2016

Next generation sequencing in non-small cell lung cancer: new avenues toward the personalized medicine

artículo científico

Next-Generation Sequencing Workflow for NSCLC Critical Samples Using a Targeted Sequencing Approach by Ion Torrent PGM™ Platform

artículo científico publicado en 2015

Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer

scientific article published in 2021

Oral vinorelbine in the treatment of non-small-cell lung cancer.

artículo científico

Organometallic compounds in oncology: implications of novel organotins as antitumor agents.

artículo científico publicado en 2009

Overexpression of cyclin D1 is associated with poor survival in epithelial ovarian cancer.

artículo científico publicado en 2004

Pemetrexed for the treatment of non-small cell lung cancer.

artículo científico publicado en 2013

Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples.

artículo científico publicado en 2016

Preclinical strategies targeted at non-small-cell lung cancer signalling pathways with striking translational fallout.

artículo científico publicado en 2012

Prediction of survival by thymidine labelling index in patients with resistant ovarian carcinoma

scientific article published on 01 January 1992

Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab

scientific article published on 10 July 2019

Prognostic and predictive relevance of circulating tumor cells in patients with non-small-cell lung cancer.

artículo científico publicado en 2014

Proliferative activity of human solid tumors evaluated by thymidine labeling index and primer-dependent alpha-DNA polymerase

scientific article published on 01 January 1986

Quinolizidinyl derivatives of iminodibenzyl and phenothiazine as multidrug resistance modulators in ovarian cancer cells.

artículo científico publicado en 2003

Radiomic detection of EGFR mutations in NSCLC

scientific article published on 04 November 2020

Relationship of variations in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancer

artículo científico publicado en 1994

Reply to the Letter to the Editor by C. Nicolazzo et al.: "Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy".

artículo científico publicado en 2017

Resistin is associated with overall survival in non-small cell lung cancer patients during nivolumab treatment

scientific article published on 11 February 2020

Role of immunotherapy in the treatment of advanced non-small-cell lung cancer.

artículo científico

Role of microRNAs in malignant mesothelioma.

artículo científico

Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors.

artículo científico publicado en 2015

Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study

scientific article published on 20 July 2019

Synthesis and biological activity of gold and tin compounds in ovarian cancer cells ⬇️

artículo científico publicado el 1 de agosto de 1998

Targeting alpha7-nicotinic receptor for the treatment of pleural mesothelioma.

artículo científico publicado en 2008

Targeting cancer-initiating cell drug-resistance: a roadmap to a new-generation of cancer therapies?

artículo científico publicado en 2011

The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancer

article

The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients

artículo científico publicado en 2019

Thymidine labelling index as prognostic factor in resected non-small cell lung cancer

artículo científico publicado en 1990

Timed sequential chemotherapy following drug-induced kinetic recruitment in refractory ovarian cancer

artículo científico publicado en 1984

Timed sequential chemotherapy following ifosfamide-induced kinetic recruitment in refractory ovarian cancer

scientific article published on 01 January 1990

Tumour kinetics, response to chemotherapy and survival in primary ovarian cancer

scientific article published on 01 January 1994

Uncommon EGFR Exon 19 Mutations Confer Gefitinib Resistance in Advanced Lung Adenocarcinoma.

artículo científico publicado en 2015

Understanding the checkpoint blockade in lung cancer immunotherapy

artículo científico publicado en 2017

Vinflunine for the treatment of non-small cell lung cancer.

artículo científico publicado en 2016

Whole exome sequencing of independent lung adenocarcinoma, lung squamous cell carcinoma, and malignant peritoneal mesothelioma: A case report

artículo científico publicado en 2016

Lista de obras de A Alama

ANTISENSE OLIGONUCLEOTIDES AS THERAPEUTIC AGENTS

Afatinib and Erlotinib in the treatment of squamous-cell lung cancer

Afatinib for the treatment of advanced non-small-cell lung cancer.

Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition.

Antitumor activity of a new orally active organotin compound: a preliminary study in murine tumor models

Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer

Belagenpumatucel-L for the treatment of non-small cell lung cancer

CD133-Positive Cells from Non-Small Cell Lung Cancer Show Distinct Sensitivity to Cisplatin and Afatinib

Caveolin‐1 is essential for metformin inhibitory effect on IGF1 action in non‐small‐cell lung cancer cells ⬇️

Cell kinetics in ovarian cancer. Relationship to clinicopathologic features, responsiveness to chemotherapy, and survival

Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.

Circulating tumor DNA reflects tumor metabolism rather than tumor burden in chemotherapy-naive patients with advanced non-small cell lung cancer (NSCLC): an (18)F-FDG PET/CT study

Clinical Applications of Circulating Tumor Cells in Lung Cancer Patients by CellSearch System

Control of Cyclin D1 Expression by Antisense Oligonucleotides in Three Ovarian Cancer Cell Lines

Correlation between B7-H4 and Survival of Non-Small-Cell Lung Cancer Patients Treated with Nivolumab

Diethylstilbestrol (DES) and recombinant human growth hormone (rhGH) as modulators of breast cancer proliferative activity

Efficacy of motesanib diphosphate in non-small-cell lung cancer

Exosomes: a new horizon in lung cancer.

Expression of Ribonucleotide Reductase Subunit-2 and Thymidylate Synthase Correlates with Poor Prognosis in Patients with Resected Stages I-III Non-Small Cell Lung Cancer

Fibroblast Growth Factor Receptor (FGFR): A New Target for Non-small Cell Lung Cancer Therapy

In vitro cytotoxic activity of tri-n-butyltin(IV)lupinylsulfide hydrogen fumarate (IST-FS 35) and preliminary antitumor activity in vivo.

Inhibition of the nicotinic acetylcholine receptors by cobra venom α-neurotoxins: is there a perspective in lung cancer treatment?

Integrated Somatic and Germline Whole-Exome Sequencing Analysis in Women with Lung Cancer after a Previous Breast Cancer.

Intraperitoneal cytosine arabinoside administered in sequence with systemic cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer

Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancer

Ipilimumab in non-small cell lung cancer and small-cell lung cancer: new knowledge on a new therapeutic strategy.

Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method.

Microtubule-targeting agents in the treatment of non-small cell lung cancer: insights on new combination strategies and investigational compounds

New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancer.

Next generation sequencing in non-small cell lung cancer: new avenues toward the personalized medicine

Next-Generation Sequencing Workflow for NSCLC Critical Samples Using a Targeted Sequencing Approach by Ion Torrent PGM™ Platform

Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer

Oral vinorelbine in the treatment of non-small-cell lung cancer.

Organometallic compounds in oncology: implications of novel organotins as antitumor agents.

Overexpression of cyclin D1 is associated with poor survival in epithelial ovarian cancer.

Pemetrexed for the treatment of non-small cell lung cancer.

Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples.

Preclinical strategies targeted at non-small-cell lung cancer signalling pathways with striking translational fallout.

Prediction of survival by thymidine labelling index in patients with resistant ovarian carcinoma

Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab

Prognostic and predictive relevance of circulating tumor cells in patients with non-small-cell lung cancer.

Proliferative activity of human solid tumors evaluated by thymidine labeling index and primer-dependent alpha-DNA polymerase

Quinolizidinyl derivatives of iminodibenzyl and phenothiazine as multidrug resistance modulators in ovarian cancer cells.

Radiomic detection of EGFR mutations in NSCLC

Relationship of variations in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancer

Reply to the Letter to the Editor by C. Nicolazzo et al.: "Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy".

Resistin is associated with overall survival in non-small cell lung cancer patients during nivolumab treatment

Role of immunotherapy in the treatment of advanced non-small-cell lung cancer.

Role of microRNAs in malignant mesothelioma.

Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors.

Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study

Synthesis and biological activity of gold and tin compounds in ovarian cancer cells ⬇️

Targeting alpha7-nicotinic receptor for the treatment of pleural mesothelioma.

Targeting cancer-initiating cell drug-resistance: a roadmap to a new-generation of cancer therapies?

The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancer

The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients

Thymidine labelling index as prognostic factor in resected non-small cell lung cancer

Timed sequential chemotherapy following drug-induced kinetic recruitment in refractory ovarian cancer

Timed sequential chemotherapy following ifosfamide-induced kinetic recruitment in refractory ovarian cancer

Tumour kinetics, response to chemotherapy and survival in primary ovarian cancer

Uncommon EGFR Exon 19 Mutations Confer Gefitinib Resistance in Advanced Lung Adenocarcinoma.

Understanding the checkpoint blockade in lung cancer immunotherapy

Vinflunine for the treatment of non-small cell lung cancer.

Whole exome sequencing of independent lung adenocarcinoma, lung squamous cell carcinoma, and malignant peritoneal mesothelioma: A case report